Aditxt, Inc. - stock earnings
ADTX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -9.7 million USD | 124486 USD |
2023Q2 | -5.7 million USD | 220978 USD |
2023Q1 | -8.7 million USD | 185596 USD |
2022Q4 | -8.2 million USD | 185596 USD |
2022Q3 | -9.7 million USD | 323125 USD |
2022Q2 | -5.9 million USD | 214715 USD |
2022Q1 | -6.0 million USD | 210279 USD |
2021Q4 | -24.1 million USD | 105034 USD |
2021Q3 | -9.8 million USD | ? USD |
2021Q2 | -6.2 million USD | ? USD |
2021Q1 | -6.4 million USD | ? USD |
2020Q4 | -4.7 million USD | ? USD |
2020Q3 | -2.7 million USD | ? USD |
2020Q2 | -534317 USD | ? USD |
2020Q1 | -1.2 million USD | ? USD |
2019Q4 | -991084 USD | ? USD |
2019Q3 | -1.1 million USD | ? USD |
2019Q2 | -2.6 million USD | ? USD |
2019Q1 | -1.2 million USD | ? USD |
2018Q4 | -500912 USD | ? USD |
2017Q4 | -212986 USD | ? USD |
ADTX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -29.6 million USD | 749475 USD |
2022 | -28.2 million USD | 933715 USD |
2021 | -48.3 million USD | 105034 USD |
2020 | -9.5 million USD | ? USD |
2019 | -5.8 million USD | ? USD |
2018 | -5.7 million USD | ? USD |
2017 | -212990 USD | ? USD |
ADTX
Price: $2.30
52 week price:
Earnings Per Share: -12.00 USD
P/E Ratio: -0.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 201000
Market Capitalization: 5.0 million